V006-9319 Screening compound: 6-(4-benzylpiperidin-1-yl)-4-(3,4-dimethoxyphenyl)-2-(3-fluorophenyl)-2H-pyrazolo[3,4-d]pyrimidin-3-amine

V006-9319 Screening compound: 6-(4-benzylpiperidin-1-yl)-4-(3,4-dimethoxyphenyl)-2-(3-fluorophenyl)-2H-pyrazolo[3,4-d]pyrimidin-3-amine
V006-9319 Screening compound: 6-(4-benzylpiperidin-1-yl)-4-(3,4-dimethoxyphenyl)-2-(3-fluorophenyl)-2H-pyrazolo[3,4-d]pyrimidin-3-amine alternative view

Chemical Structure Depiction of ChemDiv screening compound V006-9319
6-(4-benzylpiperidin-1-yl)-4-(3,4-dimethoxyphenyl)-2-(3-fluorophenyl)-2H-pyrazolo[3,4-d]pyrimidin-3-amine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V006-9319

Molecular Formula

C31H31FN6O2 (C31 H31 FN6 O2)

Compound Name

6-(4-benzylpiperidin-1-yl)-4-(3,4-dimethoxyphenyl)-2-(3-fluorophenyl)-2H-pyrazolo[3,4-d]pyrimidin-3-amine

IUPAC name

6-(4-benzylpiperidin-1-yl)-4-(34-dimethoxyphenyl)-2-(3-fluorophenyl)-2H-pyrazolo[34-d]pyrimidin-3-amine

SMILES

COc(ccc(-c(c1c2N)nc(N3CCC(Cc4ccccc4)CC3)nc1nn2-c1cccc(F)c1)c1)c1OC

InChI

InChI=1S/C31H31FN6O2/c1-39-25-12-11-22(18-26(25)40-2)28-27-29(33)38(24-10-6-9-23(32)19-24)36-30(27)35-31(34-28)37-15-13-21(14-16-37)17-20-7-4-3-5-8-20/h3-12,18-19,21H,13-17,33H2,1-2H3

InChI Key

WCGDUBBHJLJUEI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14248779

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

538.62

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

6.566

Distribution Coefficient, logD

6.565

Water Solubility, LogSw

-6.30

Polar Surface Area

70.811

Acid Dissociation Constant (pKa)

19.71

Base Dissociation Constant (pKb)

4.76

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

25.80

V006-9319 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Akt-Targeted Library (14764 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • GPCR
  • Kinases
  • Phosphatases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V006-9319 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V006-9319?
Check Price and Availability of V006-9319, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V006-9319 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V006-9319
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V006-9319
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V006-9319 available by request